pyrazolo(3,4-d)pyrimidine has been researched along with Anasarca in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashour, HM; Fahmy, SM; Khalil, MA; Labouta, IM; Nassra, RA; Tageldin, GN | 2 |
| Abd-El-Aziz, AS; Abdelghani, AA; Al Sorkhy, M; Al-Harbi, KB; Almundarij, TI; Alrawashdeh, S; Atatreh, N; El-Ashmawy, IM; Ghattas, MA; Youssef, AM | 1 |
3 other study(ies) available for pyrazolo(3,4-d)pyrimidine and Anasarca
| Article | Year |
|---|---|
Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Edema; Female; Formaldehyde; Molecular Structure; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Stomach Ulcer; Structure-Activity Relationship | 2018 |
Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidine derivatives bearing thiazolidinone moiety as anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Drug Design; Edema; Female; Granuloma; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Structure-Activity Relationship; Thiazolidines | 2018 |
Anti-inflammatory drug approach: Synthesis and biological evaluation of novel pyrazolo[3,4-d]pyrimidine compounds.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Granuloma; Humans; Inflammation; Male; Molecular Docking Simulation; Molecular Structure; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Recombinant Proteins; Structure-Activity Relationship; Turpentine | 2019 |